Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopamine D4 receptor (D4R) is a member of the dopamine receptor family and a D2-like G protein-coupled receptor (GPCR) encoded by the DRD4 gene. It is predominantly found in the prefrontal cortex and hippocampus, playing key roles in cognition, attention, impulsivity, and reward processing. Polymorphisms within DRD4 have been linked to several neuropsychiatric conditions, including ADHD, schizophrenia, and bipolar disorder. Selective ligands targeting this receptor subtype are being explored for potential therapeutic applications. Its structure and polymorphism inform rational drug design.
Inhibition of adenylate cyclase via Gi/o proteins, leading to reduced intracellular cyclic AMP levels.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine D4 Receptor (D4R).